BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

2 Acetylaminofluorene

A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

300+ PubMed studies analyzed · Evidence Score: 37.7

Research Domains

2 Acetylaminofluorene has been studied across 15 research domains including 🫁 Liver & Detox, 🔬 Oncology, 🫘 Kidney, 🧠 Focus & Attention, 🔥 Metabolic. The primary research focus is 🫁 Liver & Detox with 61% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with 2 Acetylaminofluorene, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Carboxin
12 shared targets
Linuron
10 shared targets
Secologanin
12 shared targets
Methylcholanthrene
13 shared targets
Lynestrenol
15 shared targets
Piperonyl
12 shared targets
Phenelzine
14 shared targets
thiophanate
9 shared targets
Norethindrone
13 shared targets
Mestranol
14 shared targets
Loading evidence profile...

This evidence profile for 2 Acetylaminofluorene is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.